LU86317A1 - Forme cristalline de la 7-(dimethylaminomethylene)amino-9a-methoxymitosane - Google Patents

Forme cristalline de la 7-(dimethylaminomethylene)amino-9a-methoxymitosane Download PDF

Info

Publication number: LU86317A1
Authority: LU; Luxembourg
Prior art keywords: amino; methoxymitosan; mitomycin; amorphous; am1no
Prior art date: 1985-02-21

Application number

LU86317A

Other languages

English (en)

French (fr)

Original Assignee

Bristol Myers Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-02-21

Filing date

1986-02-20

Publication date

1986-09-02

1986-02-20 Application filed by Bristol Myers Co filed Critical Bristol Myers Co

1986-09-02 Publication of LU86317A1 publication Critical patent/LU86317A1/fr

Links

-1 DIMETHYLAMINOMETHYLENE Chemical class 0.000 title description 7
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 19
238000000034 method Methods 0.000 claims description 11
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 9
238000002360 preparation method Methods 0.000 claims description 6
238000002329 infrared spectrum Methods 0.000 claims description 4
238000002425 crystallisation Methods 0.000 claims 1
230000008025 crystallization Effects 0.000 claims 1
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 27
229960004857 mitomycin Drugs 0.000 description 13
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
150000001875 compounds Chemical class 0.000 description 8
238000006243 chemical reaction Methods 0.000 description 7
YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
239000000203 mixture Substances 0.000 description 6
IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 6
238000005481 NMR spectroscopy Methods 0.000 description 5
239000013078 crystal Substances 0.000 description 5
239000003480 eluent Substances 0.000 description 5
VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
239000000047 product Substances 0.000 description 5
238000004809 thin layer chromatography Methods 0.000 description 5
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
230000000694 effects Effects 0.000 description 4
238000000855 fermentation Methods 0.000 description 4
230000004151 fermentation Effects 0.000 description 4
239000007787 solid Substances 0.000 description 4
HYFMSAFINFJTFH-UHFFFAOYSA-N Mitomycin-A Natural products O=C1C(OC)=C(C)C(=O)C2=C1C(COC(N)=O)C1(OC)N2CC2NC21 HYFMSAFINFJTFH-UHFFFAOYSA-N 0.000 description 3
238000004458 analytical method Methods 0.000 description 3
HYFMSAFINFJTFH-NGSRAFSJSA-N mitomycin A Chemical compound O=C1C(OC)=C(C)C(=O)C2=C1[C@@H](COC(N)=O)[C@]1(OC)N2C[C@@H]2N[C@@H]21 HYFMSAFINFJTFH-NGSRAFSJSA-N 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
238000003756 stirring Methods 0.000 description 3
239000000126 substance Substances 0.000 description 3
239000000725 suspension Substances 0.000 description 3
HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 2
QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
229930192392 Mitomycin Natural products 0.000 description 2
UZUUQCBCWDBYCG-UHFFFAOYSA-N Mitomycin B Natural products O=C1C(OC)=C(C)C(=O)C2=C1C(COC(N)=O)C1(O)N2CC2C1N2C UZUUQCBCWDBYCG-UHFFFAOYSA-N 0.000 description 2
JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
238000010521 absorption reaction Methods 0.000 description 2
239000003242 anti bacterial agent Substances 0.000 description 2
230000000259 anti-tumor effect Effects 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
238000003818 flash chromatography Methods 0.000 description 2
TWXDDNPPQUTEOV-FVGYRXGTSA-N methamphetamine hydrochloride Chemical compound Cl.CN[C@@H](C)CC1=CC=CC=C1 TWXDDNPPQUTEOV-FVGYRXGTSA-N 0.000 description 2
UZUUQCBCWDBYCG-DQRAMIIBSA-N mitomycin B Chemical compound O=C1C(OC)=C(C)C(=O)C2=C1[C@H](COC(N)=O)[C@]1(O)N2C[C@H]2[C@@H]1N2C UZUUQCBCWDBYCG-DQRAMIIBSA-N 0.000 description 2
238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
239000000741 silica gel Substances 0.000 description 2
229910002027 silica gel Inorganic materials 0.000 description 2
239000002904 solvent Substances 0.000 description 2
238000001228 spectrum Methods 0.000 description 2
238000003828 vacuum filtration Methods 0.000 description 2
XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 1
208000008342 Leukemia P388 Diseases 0.000 description 1
HRHKSTOGXBBQCB-UHFFFAOYSA-N Mitomycin E Natural products O=C1C(N)=C(C)C(=O)C2=C1C(COC(N)=O)C1(OC)C3N(C)C3CN12 HRHKSTOGXBBQCB-UHFFFAOYSA-N 0.000 description 1
241001529936 Murinae Species 0.000 description 1
ZSXGLVDWWRXATF-UHFFFAOYSA-N N,N-dimethylformamide dimethyl acetal Chemical compound COC(OC)N(C)C ZSXGLVDWWRXATF-UHFFFAOYSA-N 0.000 description 1
239000007832 Na2SO4 Substances 0.000 description 1
101150029512 SCG2 gene Proteins 0.000 description 1
PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
229910021529 ammonia Inorganic materials 0.000 description 1
230000000719 anti-leukaemic effect Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000002246 antineoplastic agent Substances 0.000 description 1
239000002585 base Substances 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
235000010633 broth Nutrition 0.000 description 1
125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
QQVDYSUDFZZPSU-UHFFFAOYSA-M chloromethylidene(dimethyl)azanium;chloride Chemical compound [Cl-].C[N+](C)=CCl QQVDYSUDFZZPSU-UHFFFAOYSA-M 0.000 description 1
235000019365 chlortetracycline Nutrition 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
239000000470 constituent Substances 0.000 description 1
229940127089 cytotoxic agent Drugs 0.000 description 1
125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
238000006073 displacement reaction Methods 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
239000012458 free base Substances 0.000 description 1
238000004128 high performance liquid chromatography Methods 0.000 description 1
230000010354 integration Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
206010061289 metastatic neoplasm Diseases 0.000 description 1
HRHKSTOGXBBQCB-VFWICMBZSA-N methylmitomycin Chemical compound O=C1C(N)=C(C)C(=O)C2=C1[C@@H](COC(N)=O)[C@@]1(OC)[C@H]3N(C)[C@H]3CN12 HRHKSTOGXBBQCB-VFWICMBZSA-N 0.000 description 1
125000003431 oxalo group Chemical group 0.000 description 1
238000002638 palliative care Methods 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
201000002094 pancreatic adenocarcinoma Diseases 0.000 description 1
229950004406 porfiromycin Drugs 0.000 description 1
239000000843 powder Substances 0.000 description 1
150000003141 primary amines Chemical class 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
150000003335 secondary amines Chemical class 0.000 description 1
229910052938 sodium sulfate Inorganic materials 0.000 description 1
235000011152 sodium sulphate Nutrition 0.000 description 1
239000007858 starting material Substances 0.000 description 1
210000002784 stomach Anatomy 0.000 description 1
238000003860 storage Methods 0.000 description 1
230000001502 supplementing effect Effects 0.000 description 1
239000006188 syrup Substances 0.000 description 1
235000020357 syrup Nutrition 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000002211 ultraviolet spectrum Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Luminescent Compositions (AREA)

LU86317A 1985-02-21 1986-02-20 Forme cristalline de la 7-(dimethylaminomethylene)amino-9a-methoxymitosane LU86317A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US06/703,778 US4639528A (en)	1985-02-21	1985-02-21	Crystalline form of 7-(dimethylaminomethylene-amino-9a-methoxymitosane
US70377885		1985-02-21

Publications (1)

Publication Number	Publication Date
LU86317A1 true LU86317A1 (fr)	1986-09-02

Family

ID=24826748

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LU86317A LU86317A1 (fr)	1985-02-21	1986-02-20	Forme cristalline de la 7-(dimethylaminomethylene)amino-9a-methoxymitosane

Country Status (33)

Country	Link
US (1)	US4639528A (de)
JP (1)	JPS61194086A (de)
KR (1)	KR930003075B1 (de)
CN (1)	CN1013495B (de)
AR (1)	AR241269A1 (de)
AU (1)	AU595183B2 (de)
BE (1)	BE904259A (de)
CA (1)	CA1273635A (de)
CH (1)	CH666687A5 (de)
CY (1)	CY1587A (de)
DD (1)	DD243285A5 (de)
DE (1)	DE3605527A1 (de)
DK (1)	DK163241C (de)
EG (1)	EG17775A (de)
ES (1)	ES8705249A1 (de)
FI (1)	FI860720L (de)
FR (1)	FR2577554B1 (de)
GB (1)	GB2171406B (de)
GR (1)	GR860510B (de)
HK (1)	HK22291A (de)
HU (1)	HU193628B (de)
IT (1)	IT1188701B (de)
LU (1)	LU86317A1 (de)
MY (1)	MY101451A (de)
NL (1)	NL8600432A (de)
NO (1)	NO162021C (de)
NZ (1)	NZ215017A (de)
OA (1)	OA08207A (de)
PT (1)	PT82059B (de)
SE (1)	SE468596B (de)
SU (1)	SU1375138A3 (de)
YU (1)	YU44598B (de)
ZA (1)	ZA86249B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA86308B (en) *	1985-02-25	1986-11-26	Bristol Myers Co	In-vial deposition of 7-(dimethylaminomethylene)amino-9a-methoxy-mitosane
JPS6335520A (ja) *	1986-07-31	1988-02-16	Kyowa Hakko Kogyo Co Ltd	抗腫瘍剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4156735A (en) *	1976-01-17	1979-05-29	Hoechst Aktiengesellschaft	Thiazolidine derivatives
IE45511B1 (en) *	1976-09-01	1982-09-08	Ciba Geigy Ag	New derivatives of perhydro-aza-heterocycles and processesfor the production thereof
JPS588397B2 (ja) *	1978-07-18	1983-02-15	協和醗酵工業株式会社	新規なマイトマイシン誘導体およびその製造法
DE3220378C2 (de) *	1982-05-29	1994-03-03	Heidelberger Druckmasch Ag	Steuervorrichtung für eine Druckmaschine
US4487769A (en) *	1982-06-04	1984-12-11	Bristol-Myers Company	Amidines
US4478769A (en) *	1982-09-30	1984-10-23	Amerace Corporation	Method for forming an embossing tool with an optically precise pattern

1985
- 1985-02-21 US US06/703,778 patent/US4639528A/en not_active Expired - Fee Related
1986
- 1986-01-02 CA CA000498870A patent/CA1273635A/en not_active Expired - Lifetime
- 1986-01-13 ZA ZA86249A patent/ZA86249B/xx unknown
- 1986-02-03 NZ NZ215017A patent/NZ215017A/xx unknown
- 1986-02-05 CN CN86100944A patent/CN1013495B/zh not_active Expired
- 1986-02-11 FR FR868601815A patent/FR2577554B1/fr not_active Expired
- 1986-02-12 JP JP61028743A patent/JPS61194086A/ja active Pending
- 1986-02-18 IT IT19439/86A patent/IT1188701B/it active
- 1986-02-18 AU AU53685/86A patent/AU595183B2/en not_active Ceased
- 1986-02-18 FI FI860720A patent/FI860720L/fi not_active Application Discontinuation
- 1986-02-19 ES ES552186A patent/ES8705249A1/es not_active Expired
- 1986-02-20 DE DE19863605527 patent/DE3605527A1/de not_active Withdrawn
- 1986-02-20 EG EG84/86A patent/EG17775A/xx active
- 1986-02-20 CH CH679/86A patent/CH666687A5/de not_active IP Right Cessation
- 1986-02-20 YU YU258/86A patent/YU44598B/xx unknown
- 1986-02-20 PT PT82059A patent/PT82059B/pt not_active IP Right Cessation
- 1986-02-20 DD DD86287197A patent/DD243285A5/de not_active IP Right Cessation
- 1986-02-20 KR KR1019860001171A patent/KR930003075B1/ko not_active Expired - Fee Related
- 1986-02-20 BE BE0/216293A patent/BE904259A/fr not_active IP Right Cessation
- 1986-02-20 NO NO860633A patent/NO162021C/no unknown
- 1986-02-20 SE SE8600778A patent/SE468596B/sv not_active IP Right Cessation
- 1986-02-20 DK DK079886A patent/DK163241C/da not_active IP Right Cessation
- 1986-02-20 SU SU864023029A patent/SU1375138A3/ru active
- 1986-02-20 OA OA58789A patent/OA08207A/xx unknown
- 1986-02-20 AR AR86303185A patent/AR241269A1/es active
- 1986-02-20 GB GB08604201A patent/GB2171406B/en not_active Expired
- 1986-02-20 NL NL8600432A patent/NL8600432A/nl not_active Application Discontinuation
- 1986-02-20 LU LU86317A patent/LU86317A1/fr unknown
- 1986-02-20 HU HU86710A patent/HU193628B/hu not_active IP Right Cessation
- 1986-02-21 GR GR860510A patent/GR860510B/el unknown
1987
- 1987-09-28 MY MYPI87002082A patent/MY101451A/en unknown
1991
- 1991-03-26 HK HK222/91A patent/HK22291A/xx unknown
1992
- 1992-04-03 CY CY1587A patent/CY1587A/en unknown

Also Published As

Publication number	Publication date
YU44598B (en)	1990-10-31
PT82059B (pt)	1988-07-01
MY101451A (en)	1991-11-18
ES8705249A1 (es)	1987-05-01
NZ215017A (en)	1989-06-28
CH666687A5 (de)	1988-08-15
IT1188701B (it)	1988-01-28
IT8619439A0 (it)	1986-02-18
DD243285A5 (de)	1987-02-25
NL8600432A (nl)	1986-09-16
CY1587A (en)	1992-04-03
SE8600778D0 (sv)	1986-02-20
SE468596B (sv)	1993-02-15
HU193628B (en)	1987-11-30
DK163241B (da)	1992-02-10
HK22291A (en)	1991-04-04
GB2171406B (en)	1988-08-10
PT82059A (en)	1986-03-01
EG17775A (en)	1991-06-30
FI860720A7 (fi)	1986-08-22
DE3605527A1 (de)	1986-08-21
CN1013495B (zh)	1991-08-14
DK163241C (da)	1992-06-29
AU595183B2 (en)	1990-03-29
GR860510B (en)	1986-06-24
SE8600778L (sv)	1986-08-22
KR930003075B1 (ko)	1993-04-17
YU25886A (en)	1988-04-30
FI860720A0 (fi)	1986-02-18
AR241269A1 (es)	1992-04-30
NO162021B (no)	1989-07-17
SU1375138A3 (ru)	1988-02-15
US4639528A (en)	1987-01-27
FR2577554B1 (fr)	1989-12-29
FR2577554A1 (fr)	1986-08-22
GB8604201D0 (en)	1986-03-26
IT8619439A1 (it)	1987-08-18
HUT40565A (en)	1987-01-28
DK79886D0 (da)	1986-02-20
AU5368586A (en)	1986-08-28
NO162021C (no)	1989-10-25
BE904259A (fr)	1986-08-20
ZA86249B (en)	1986-08-27
CA1273635A (en)	1990-09-04
OA08207A (fr)	1987-10-30
JPS61194086A (ja)	1986-08-28
ES552186A0 (es)	1987-05-01
CN86100944A (zh)	1986-11-05
DK79886A (da)	1986-08-22
GB2171406A (en)	1986-08-28
FI860720L (fi)	1986-08-22
KR860006468A (ko)	1986-09-11
NO860633L (no)	1986-08-22

Publication	Publication Date	Title
FR2461711A1 (fr)	1981-02-06	Composes du 1h-pyrrolo-(2,1-c) (1,4) benzodiazepine-2-acrylamide, leur procede de preparation et compositions pharmaceutiques en contenant
WO1992019620A1 (fr)	1992-11-12	Nouveaux derives de pyrrolo [1, 4]-benzodiazepines, leur procede de preparation et medicaments les contenant
FR2477016A1 (fr)	1981-09-04	Compositions pharmaceutiques a base de derives de mitomycine pour le traitement de maladie neoplastique chez les animaux
EP0147317A2 (de)	1985-07-03	Ortho-kondensierte Pyrrolderivate, ihre Herstellung und diese enthaltende Arzneimittel
FR2543953A1 (fr)	1984-10-12	Analogue de la mitomycine comportant un groupe disulfure, leur preparation et leur application pharmacologique
CH629218A5 (fr)	1982-04-15	Procede de preparation de derives du glucopyranose-nitrosouree.
BE897843A (fr)	1984-01-16	Derives biologiquement actifs de 2, 5-piperazinediones, procede pour leur preparation et compositions pharmaceutique en contenant
LU86317A1 (fr)	1986-09-02	Forme cristalline de la 7-(dimethylaminomethylene)amino-9a-methoxymitosane
EP1042326B1 (de)	2002-06-19	Acronycinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
KR880001284B1 (ko)	1988-07-18	아지노 리파마이신 화합물의 제조방법
FR2557112A1 (fr)	1985-06-28	Acylamino mitosanes
FR2492385A1 (fr)	1982-04-23	Nouveaux composes cytostatiques derives de la vinblastine, leur procede de preparation et composition pharmaceutique les contenant
CH639075A5 (fr)	1983-10-31	Ethers dibenzyliques substitues actifs sur le plan therapeutique.
AU2023325622A1 (en)	2025-02-13	Crystal form of pyrazolopyrimidine ester compound and preparation method therefor
CZ242094A3 (en)	1995-01-18	Process for preparing pure oxytetracycline and intermediate for the preparation thereof
CA1276632C (en)	1990-11-20	Nitro derivatives of vinblastine-type bisindoles, pharmaceutical compositions containing them and process for preparing same
EP0044238A1 (de)	1982-01-20	Cephalosporinsulfoxyd-Verbindungen, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Präparate
FR2610627A1 (fr)	1988-08-12	Sels cristallins de l'acide (3s(z))-2(((1-(2-amino-4-thiazolyl)-2-((2,2-dimethyl-4-oxo-1-(sulfo-oxy)-3-azetidinyl)amino)-2-oxoethylidene)-amino)oxy)acetique, a action therapeutique
EP0699679A1 (de)	1996-03-06	Tetrahydropyranylderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
BE867095A (fr)	1978-11-16	Nouveaux derives sesquiterpeniques utiles notamment comme inhibiteurs du systeme complementaire et leurs procedes de preparation
FR2492384A1 (fr)	1982-04-23	Procede de preparation de nouveaux composes cytostatiques et compositions pharmaceutiques les contenant
FR2475552A1 (fr)	1981-08-14	Derives de la rifamycine s ou sv, leurs procedes de preparation et les compositions pharmaceutiques qui les utilisent
LU86320A1 (fr)	1986-09-02	Depot en fioles de 7-(dimethylaminomethylene)amino-9a-methoxymitosane
BE856403A (fr)	1977-10-31	Derives d'imidazole-4-carboxamide 5-0-acyles, procede pour leur preparation et medicaments en contenant
US4251517A (en)	1981-02-17	Unsaturated or substituted methyl ethers having antibiotic activity